Ibero-American Expert Consensus on Squamous Cell Carcinoma of the Head and Neck Treatment in Patients Unable to Receive Cisplatin: Recommendations for Clinical Practice

Agustín Falco1 Instituto Alexander Fleming, Asociación Argentina de Oncología Clínica (AAOC), Buenos Aires, Argentina

Thiago Bueno de Oliveira2 AC Camargo Cancer Center, Sociedade Brasileira de Oncologia Clínica (SBOC), São Paulo, Brazil

https://orcid.org/0000-0002-6472-3596

Jon Cacicedo3 Hospital Universitario Cruces/Biocruces Bizkaia Health Research Institute, Barakaldo, Bizkaia, Spain

Aylen Vanessa Ospina4 ICCAL, Hospital Universitario Fundación Santa Fe de Bogotá, Asociación Colombiana de Hematología y Oncología (ACHO), Bogotá, Colombia

Miguel Ángel Ticona5 Hospital Nacional Edgardo Rebagliati Martins de Lima, Sociedad Peruana de Oncología Médica (SPOM), Lima, Perú

Héctor Galindo6 Pontificia Universidad Católica de Chile, Sociedad Chilena de Oncología Médica (SCOM), Santiago, Chile

Marcos David Pereira7 Instituto de Oncología Ángel H. Roffo, Asociación Argentina de Oncología Clínica (AAOC), Buenos Aires, Argentina

José Luis Aguilar-Ponce8 Instituto Nacional de Cancerología, Sociedad Mexicana de Oncología (SMeO), Mexico City, Mexico

Antonio Rueda-Domínguez9 UGC Oncología Médica, Hospital Universitario Regional y Virgen de la Victoria, IBIMA, Málaga, Spain

Tannia Soria10 Hospital SOLCA de Quito, Sociedad Ecuatoriana de Oncología (SEO), Quito, Ecuador

Miren Taberna11 Institut Català d’Oncologia, ICO L’Hospitalet, Barcelona, Spain

Lara Iglesias12 Hospital 12 de Octubre, Madrid, Spain

Taysser Sowley13 Instituto Oncológico Nacional (ION) de Panamá, Sociedad Panameña de Oncología (SPO), Panama City, Panama

Ricard Mesía14 Institut Català d’Oncologia, ICO Badalona, Barcelona, SpainCorrespondence[email protected]

https://orcid.org/0000-0002-3785-3563

& On behalf of TTCC group (Spanish Group for the Treatment of the Head and Neck Cancer) show all

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Articles from other publishers (4)

Alexander Rühle, Maria Weymann, Max Behrens, Sebastian Marschner, Marlen Haderlein, Alexander Fabian, Carolin Senger, Daniel R. Dickstein, Johannes Kraft, Jens von der Grün, Eric Chen, Todd Aquino-Michaels, Justus Domschikowski, Amanda Bickel, Alev Altay-Langguth, Goda Kalinauskaite, Victor Lewitzki, Marcelo Bonomi, Dukagjin M. Blakaj, Sachin R. Jhawar, Sujith Baliga, Rahul Barve, Konstantinos Ferentinos, Constantinos Zamboglou, Sören Schnellhardt, Erik Haehl, Simon K.B. Spohn, Thomas Kuhnt, Daniela Zöller, Matthias Guckenberger, Volker Budach, Claus Belka, Richard Bakst, Arnulf Mayer, Heinz Schmidberger, Anca-Ligia Grosu, Panagiotis Balermpas, Carmen Stromberger & Nils H. Nicolay. (2024) A Multicenter Evaluation of Different Chemotherapy Regimens in Older Adults With Head and Neck Squamous Cell Carcinoma Undergoing Definitive Chemoradiation. International Journal of Radiation Oncology*Biology*Physics 118:5, pages 1282-1293.
Crossref

Robert L Ferris, Hisham Mehanna, Jonathan D Schoenfeld, Makoto Tahara, Sue S Yom, Robert Haddad, André König, Pauline Witzler, Marcis Bajars & Christophe Le Tourneau. (2024) Xevinapant plus radiotherapy in resected, high-risk, cisplatin-ineligible LA SCCHN: the phase III XRay Vision study design. Future Oncology.
Crossref

Robert I. Haddad, Kevin Harrington, Makoto Tahara, Petr Szturz, Christophe Le Tourneau, Satu Salmio, Marcis Bajars & Nancy Y. Lee. (2023) Managing cisplatin-ineligible patients with resected, high-risk, locally advanced squamous cell carcinoma of the head and neck: Is there a standard of care?. Cancer Treatment Reviews 119, pages 102585.
Crossref

Jordi Rubió-Casadevall, Beatriz Cirauqui Cirauqui, Javier Martinez Trufero, Maria Plana Serrahima, Almudena García Castaño, Alberto Carral Maseda, Lara Iglesias Docampo, Pedro Pérez Segura, Isaac Ceballos Lenza, Vanesa Gutiérrez Calderón, José Fuster Salvà, Carolina Pena Álvarez, Irene Hernandez, Edel del Barco Morillo, Manuel Chaves Conde, Joaquina Martínez Galán, Marisa Durán Sánchez, Vanesa Quiroga, Eugenia Ortega & Ricard Mesia. (2023) TTCC-2019-02: real-world evidence of first-line cetuximab plus paclitaxel in recurrent or metastatic squamous cell carcinoma of the head and neck. Frontiers in Oncology 13.
Crossref

Ibero-American Expert Consensus on Squamous Cell Carcinoma of the Head and Neck Treatment in Patients Unable to Receive Cisplatin: Recommendations for Clinical Practice

Articles from other publishers (4)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Ibero-American Expert Consensus on Squamous Cell Carcinoma of the Head and Neck Treatment in Patients Unable to Receive Cisplatin: Recommendations for Clinical Practice

Citations (4)

Articles from other publishers (4)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date